Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 13 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading
Hadjipavlou G, Cortese A M, Ramaswamy B. Spinal cord injury and chronic pain. BJA Education 2016; 16: 264–268.
Reck T, Landmann G. Successful spinal cord stimulation for neuropathic below-level spinal cord injury pain following complete paraplegia: a case report. Spinal Cord Series and Cases 2017;3 doi: 10.1038/scsandc.2017.49
Fregni F, Boggio P, Lima M et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. PAIN 2006; 122: 197–209.
Dones I, Levi V. Spinal cord stimulation for neuropathic pain: current trends and future applications. Brain Sciences 2018;8 doi: 10.3390/brainsci8080138
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
